Mirum Pharmaceuticals, Inc. (MIRM) Prices 3.75M Share Common Offering at $20/Sh

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced the pricing of its previously announced underwritten public offering of 3,750,000 shares of its common stock at a price to the public of $20.00 per share. The gross proceeds to Mirum from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $75.0 million.

In addition, Mirum has granted the underwriters a 30-day option to purchase up to an additional 562,500 shares of common stock at the public offering price less underwriting discounts and commissions. The offering is expected to close on December 17, 2020, subject to satisfaction of customary closing conditions.

J.P. Morgan, SVB Leerink and Evercore ISI are acting as joint book-running managers for the offering. H.C. Wainwright & Co. is acting as lead manager for the offering.

You May Also Be Interested In

• TikTok owner ByteDance said to secure $29.6bn loan for AI push
• Phreesia Inc. (PHR) files mixed shelf
• Dutch Bros Inc. (BROS) files mixed shelf